<DOC>
	<DOCNO>NCT02233452</DOCNO>
	<brief_summary>Methadone ketamine effective neuropathic pain management . However , benefit association drug uncertain . Here , investigator conduct randomized , double-blind , parallel , active control clinical trial test hypothesis methadone combine ketamine ( methadone/ketamine ) effective methadone ketamine alone reduce neuropathic pain .</brief_summary>
	<brief_title>Methadone Ketamine Neuropathic Pain Treatment</brief_title>
	<detailed_description>Either oral methadone ketamine use neuropathic pain management , however , benefit association drug uncertain . Here , conduct randomize , double-blind , parallel , active control clinical trial test hypothesis methadone combine ketamine ( methadone/ketamine ) effective methadone ketamine alone reduce neuropathic pain . Methods : Fourthly two patient neuropathic pain refractory conventional therapy randomly assign receive three month oral methadone ( n= 13 ) , ketamine ( n=13 ) methadone combine ketamine ( n=13 ) . The primary outcome pain score visual analogical scale ( VAS ) assess baseline , 8 , 15 , 30 , 60 90 day throughout treatment , secondary outcome symptoms neuropathic pain allodynia , burn shoot pain well side effect .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>patient complain pain 6 month neuropathic pain poorly responsive drug use treat neuropathic pain ( i.e . opioid , nonopioid , anticonvulsant , antidepressant ) , 22 77 year old patient history severe psychiatric disorder , misuse illegal drug hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Neuropathic pain</keyword>
	<keyword>Methadone</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Multimodal analgesia</keyword>
</DOC>